

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phospholipid efflux (GO:0033700) | 6.36230887 |
| 2 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 6.27801275 |
| 3 | oligosaccharide catabolic process (GO:0009313) | 6.23379464 |
| 4 | negative regulation of sterol transport (GO:0032372) | 6.16217062 |
| 5 | negative regulation of cholesterol transport (GO:0032375) | 6.16217062 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66234527 |
| 7 | low-density lipoprotein particle remodeling (GO:0034374) | 5.65057110 |
| 8 | membrane repolarization during action potential (GO:0086011) | 5.59125079 |
| 9 | regulation of cholesterol esterification (GO:0010872) | 5.52551667 |
| 10 | plasma lipoprotein particle assembly (GO:0034377) | 5.33362719 |
| 11 | vitamin A metabolic process (GO:0006776) | 5.21077538 |
| 12 | reverse cholesterol transport (GO:0043691) | 5.17645649 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 4.94773626 |
| 14 | protein-lipid complex remodeling (GO:0034368) | 4.92887683 |
| 15 | macromolecular complex remodeling (GO:0034367) | 4.92887683 |
| 16 | plasma lipoprotein particle remodeling (GO:0034369) | 4.92887683 |
| 17 | DNA deamination (GO:0045006) | 4.85226388 |
| 18 | purine nucleobase biosynthetic process (GO:0009113) | 4.77340308 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 4.67662313 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.67311733 |
| 21 | nucleobase biosynthetic process (GO:0046112) | 4.64463182 |
| 22 | protein-lipid complex assembly (GO:0065005) | 4.59986943 |
| 23 | cholesterol efflux (GO:0033344) | 4.56151974 |
| 24 | plasma lipoprotein particle organization (GO:0071827) | 4.51910712 |
| 25 | folic acid metabolic process (GO:0046655) | 4.46137503 |
| 26 | ribosome assembly (GO:0042255) | 4.45256328 |
| 27 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.43266199 |
| 28 | positive regulation of fatty acid oxidation (GO:0046321) | 4.36864359 |
| 29 | ribosomal small subunit assembly (GO:0000028) | 4.35369103 |
| 30 | formation of translation preinitiation complex (GO:0001731) | 4.28927535 |
| 31 | ribosome biogenesis (GO:0042254) | 4.25615789 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 4.22703650 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 4.18742137 |
| 34 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.17133622 |
| 35 | protein-lipid complex subunit organization (GO:0071825) | 4.16824047 |
| 36 | glycine metabolic process (GO:0006544) | 4.13607601 |
| 37 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.10234238 |
| 38 | viral transcription (GO:0019083) | 4.04381538 |
| 39 | interkinetic nuclear migration (GO:0022027) | 4.03071341 |
| 40 | translational termination (GO:0006415) | 4.01481745 |
| 41 | ribosomal large subunit biogenesis (GO:0042273) | 4.00390341 |
| 42 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.99133185 |
| 43 | DNA replication initiation (GO:0006270) | 3.96299632 |
| 44 | regulation of somitogenesis (GO:0014807) | 3.96272201 |
| 45 | cellular response to electrical stimulus (GO:0071257) | 3.94173031 |
| 46 | cardiovascular system development (GO:0072358) | 3.89588500 |
| 47 | cGMP-mediated signaling (GO:0019934) | 3.85435727 |
| 48 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.74597093 |
| 49 | translational initiation (GO:0006413) | 3.73556569 |
| 50 | translational elongation (GO:0006414) | 3.71279655 |
| 51 | glycosphingolipid catabolic process (GO:0046479) | 3.64059116 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 3.60725764 |
| 53 | DNA replication checkpoint (GO:0000076) | 3.59914347 |
| 54 | reactive oxygen species biosynthetic process (GO:1903409) | 3.55574180 |
| 55 | DNA strand elongation (GO:0022616) | 3.55065556 |
| 56 | rRNA processing (GO:0006364) | 3.51847150 |
| 57 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.49712679 |
| 58 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.49712679 |
| 59 | neuronal stem cell maintenance (GO:0097150) | 3.49380704 |
| 60 | membrane repolarization (GO:0086009) | 3.45990369 |
| 61 | mitotic metaphase plate congression (GO:0007080) | 3.40922928 |
| 62 | rRNA metabolic process (GO:0016072) | 3.40245135 |
| 63 | phosphate ion homeostasis (GO:0055062) | 3.39372782 |
| 64 | trivalent inorganic anion homeostasis (GO:0072506) | 3.39372782 |
| 65 | lung epithelium development (GO:0060428) | 3.39185039 |
| 66 | DNA unwinding involved in DNA replication (GO:0006268) | 3.38090343 |
| 67 | proteasome assembly (GO:0043248) | 3.36966389 |
| 68 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.36399317 |
| 69 | glycolipid catabolic process (GO:0019377) | 3.33722999 |
| 70 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.32512731 |
| 71 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.31588814 |
| 72 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.31333910 |
| 73 | lipoprotein metabolic process (GO:0042157) | 3.30681283 |
| 74 | spliceosomal snRNP assembly (GO:0000387) | 3.29729147 |
| 75 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.28718644 |
| 76 | behavioral response to nicotine (GO:0035095) | 3.26616266 |
| 77 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.25843784 |
| 78 | pseudouridine synthesis (GO:0001522) | 3.23508542 |
| 79 | cellular response to cholesterol (GO:0071397) | 3.23428476 |
| 80 | somite development (GO:0061053) | 3.21663750 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 3.21651148 |
| 82 | protein targeting to ER (GO:0045047) | 3.20683502 |
| 83 | cotranslational protein targeting to membrane (GO:0006613) | 3.20133691 |
| 84 | mitotic nuclear envelope disassembly (GO:0007077) | 3.18839599 |
| 85 | rRNA modification (GO:0000154) | 3.18447028 |
| 86 | intestinal epithelial cell development (GO:0060576) | 3.17212541 |
| 87 | sulfate transmembrane transport (GO:1902358) | 3.16391015 |
| 88 | regulation of membrane repolarization (GO:0060306) | 3.16020138 |
| 89 | mesenchymal cell proliferation (GO:0010463) | 3.14772194 |
| 90 | superoxide anion generation (GO:0042554) | 3.14561282 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13702976 |
| 92 | regulation of DNA endoreduplication (GO:0032875) | 3.11787971 |
| 93 | serine family amino acid metabolic process (GO:0009069) | 3.11769052 |
| 94 | IMP biosynthetic process (GO:0006188) | 3.11140598 |
| 95 | cellular protein complex disassembly (GO:0043624) | 3.11078982 |
| 96 | termination of RNA polymerase III transcription (GO:0006386) | 3.09641541 |
| 97 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.09641541 |
| 98 | protein localization to endoplasmic reticulum (GO:0070972) | 3.08700575 |
| 99 | serine family amino acid catabolic process (GO:0009071) | 3.07941144 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.07796437 |
| 101 | viral life cycle (GO:0019058) | 3.07662309 |
| 102 | folic acid-containing compound metabolic process (GO:0006760) | 3.07066749 |
| 103 | regulation of mesoderm development (GO:2000380) | 3.06990080 |
| 104 | intestinal cholesterol absorption (GO:0030299) | 3.06961135 |
| 105 | L-serine metabolic process (GO:0006563) | 3.06348113 |
| 106 | regulation of lipoprotein particle clearance (GO:0010984) | 3.05535580 |
| 107 | positive regulation of cholesterol efflux (GO:0010875) | 3.05354317 |
| 108 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.04714431 |
| 109 | regulation of triglyceride catabolic process (GO:0010896) | 3.04328875 |
| 110 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.02937863 |
| 111 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.02755211 |
| 112 | flavonoid metabolic process (GO:0009812) | 3.02175569 |
| 113 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.02018832 |
| 114 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.02018832 |
| 115 | regulation of fatty acid oxidation (GO:0046320) | 3.01909449 |
| 116 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.01899190 |
| 117 | * regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.00386670 |
| 118 | dorsal/ventral neural tube patterning (GO:0021904) | 2.99269569 |
| 119 | cellular component biogenesis (GO:0044085) | 2.97734970 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 2.96615403 |
| 121 | L-methionine salvage (GO:0071267) | 2.96205864 |
| 122 | L-methionine biosynthetic process (GO:0071265) | 2.96205864 |
| 123 | amino acid salvage (GO:0043102) | 2.96205864 |
| 124 | translation (GO:0006412) | 2.93541320 |
| 125 | nuclear envelope disassembly (GO:0051081) | 2.93437193 |
| 126 | membrane disassembly (GO:0030397) | 2.93437193 |
| 127 | lateral sprouting from an epithelium (GO:0060601) | 2.91920922 |
| 128 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.91305973 |
| 129 | magnesium ion transport (GO:0015693) | 2.90789505 |
| 130 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.90731471 |
| 131 | alanine transport (GO:0032328) | 2.90436260 |
| 132 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.90190281 |
| 133 | tetrahydrofolate metabolic process (GO:0046653) | 2.88947346 |
| 134 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.88565327 |
| 135 | telomere maintenance via recombination (GO:0000722) | 2.88289032 |
| 136 | regulation of cholesterol homeostasis (GO:2000188) | 2.87319830 |
| 137 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.87169084 |
| 138 | regulation of cholesterol storage (GO:0010885) | 2.86995274 |
| 139 | midbrain development (GO:0030901) | 2.85774601 |
| 140 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.85561276 |
| 141 | ceramide catabolic process (GO:0046514) | 2.85424635 |
| 142 | nucleus localization (GO:0051647) | 2.85051648 |
| 143 | metaphase plate congression (GO:0051310) | 2.84675891 |
| 144 | protein localization to kinetochore (GO:0034501) | 2.84602900 |
| 145 | axon ensheathment in central nervous system (GO:0032291) | 2.84401868 |
| 146 | central nervous system myelination (GO:0022010) | 2.84401868 |
| 147 | nucleoside salvage (GO:0043174) | 2.84161110 |
| 148 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.82178215 |
| 149 | lung lobe morphogenesis (GO:0060463) | 2.82006199 |
| 150 | negative regulation of lipid transport (GO:0032369) | 2.81277985 |
| 151 | pteridine-containing compound metabolic process (GO:0042558) | 2.80971616 |
| 152 | regulation of translational termination (GO:0006449) | 2.80971378 |
| 153 | protein complex disassembly (GO:0043241) | 2.79367867 |
| 154 | positive regulation of gastrulation (GO:2000543) | 2.79354624 |
| 155 | regulation of bile acid biosynthetic process (GO:0070857) | 2.77637009 |
| 156 | regulation of spindle organization (GO:0090224) | 2.77102271 |
| 157 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.76612761 |
| 158 | vitamin D metabolic process (GO:0042359) | 2.74726602 |
| 159 | methionine metabolic process (GO:0006555) | 2.74491431 |
| 160 | response to electrical stimulus (GO:0051602) | 2.74228489 |
| 161 | sulfur amino acid biosynthetic process (GO:0000097) | 2.73421656 |
| 162 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.73149497 |
| 163 | one-carbon metabolic process (GO:0006730) | 2.72872754 |
| 164 | positive regulation of cholesterol transport (GO:0032376) | 2.72737128 |
| 165 | positive regulation of sterol transport (GO:0032373) | 2.72737128 |
| 166 | IMP metabolic process (GO:0046040) | 2.72418454 |
| 167 | diacylglycerol metabolic process (GO:0046339) | 2.72386952 |
| 168 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.72100170 |
| 169 | positive regulation of synapse maturation (GO:0090129) | 2.71643461 |
| 170 | intestinal absorption (GO:0050892) | 2.70987493 |
| 171 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.69673076 |
| 172 | telomere maintenance via telomere lengthening (GO:0010833) | 2.68969676 |
| 173 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.68173732 |
| 174 | macromolecular complex disassembly (GO:0032984) | 2.67145778 |
| 175 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.67100623 |
| 176 | methionine biosynthetic process (GO:0009086) | 2.67022557 |
| 177 | cellular response to sterol (GO:0036315) | 2.66737826 |
| 178 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.66404770 |
| 179 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.66288034 |
| 180 | negative regulation of ligase activity (GO:0051352) | 2.66288034 |
| 181 | folic acid transport (GO:0015884) | 2.65343306 |
| 182 | sulfate transport (GO:0008272) | 2.64681374 |
| 183 | cellular anion homeostasis (GO:0030002) | 2.64589737 |
| 184 | protein localization to chromosome, centromeric region (GO:0071459) | 2.64310537 |
| 185 | sulfation (GO:0051923) | 2.63791468 |
| 186 | ncRNA processing (GO:0034470) | 2.63277561 |
| 187 | nuclear pore organization (GO:0006999) | 2.63114373 |
| 188 | regulation of translation in response to stress (GO:0043555) | 2.62882211 |
| 189 | cell proliferation involved in metanephros development (GO:0072203) | 2.62716467 |
| 190 | maturation of 5.8S rRNA (GO:0000460) | 2.62293955 |
| 191 | mitochondrial RNA metabolic process (GO:0000959) | 2.62208525 |
| 192 | tRNA methylation (GO:0030488) | 2.62082034 |
| 193 | mitotic recombination (GO:0006312) | 2.59820843 |
| 194 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.59599826 |
| 195 | ncRNA metabolic process (GO:0034660) | 2.58910523 |
| 196 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.58012710 |
| 197 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.56703727 |
| 198 | cell cycle G1/S phase transition (GO:0044843) | 2.56703727 |
| 199 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.55806639 |
| 200 | L-phenylalanine metabolic process (GO:0006558) | 2.55806639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.61578173 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.38019164 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.19762836 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.91235723 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.89544330 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.23344009 |
| 7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.07669328 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.93599279 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87199520 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.85590348 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.84833250 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.79169657 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.73951086 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.66361163 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.64846784 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.55476188 |
| 17 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.47371707 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.45028391 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.43291931 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37996646 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.36728851 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.29982552 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.28703862 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.24524346 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22982636 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.18491414 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.15595115 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.14799529 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.11512402 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08565196 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.08276538 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06712020 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.04059421 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.02390107 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01461797 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.01252133 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95125072 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.95117242 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94645819 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94542214 |
| 41 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.94027887 |
| 42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93865523 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90547492 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88494047 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.88151724 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.87855455 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86550912 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86000331 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.83414325 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.83106558 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81607859 |
| 52 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.80927590 |
| 53 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.74963494 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74138457 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71202407 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68685667 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68458669 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.68269043 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68032510 |
| 60 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64307253 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.63469389 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.62311586 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62297490 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.61627982 |
| 65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.60857723 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59765304 |
| 67 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.58925227 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57604062 |
| 69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.56614143 |
| 70 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56259230 |
| 71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.55040561 |
| 72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.54291923 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53878982 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.52620978 |
| 75 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.49822164 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.49631550 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49168295 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49168295 |
| 79 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46964046 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.46662134 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.46430941 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46329650 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45874059 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.45016541 |
| 85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44666968 |
| 86 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.44363228 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.44032356 |
| 88 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.43711021 |
| 89 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42791247 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.41742721 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41350957 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40664127 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39014659 |
| 94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38937550 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38824661 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37050763 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36016016 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.35567735 |
| 99 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32839556 |
| 100 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32687845 |
| 101 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31122886 |
| 102 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30711839 |
| 103 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29638538 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29282673 |
| 105 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27558327 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25304729 |
| 107 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23781863 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22474342 |
| 109 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21734244 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21734244 |
| 111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21364000 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21329101 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19954266 |
| 114 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19518096 |
| 115 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18554964 |
| 116 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16801156 |
| 117 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16576856 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16267450 |
| 119 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16120244 |
| 120 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15577906 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14540538 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13999012 |
| 123 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13703448 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13263425 |
| 125 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11426416 |
| 126 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11279102 |
| 127 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10885627 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10188988 |
| 129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09537615 |
| 130 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09125367 |
| 131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08306766 |
| 132 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08236696 |
| 133 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.08136574 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07617607 |
| 135 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06010249 |
| 136 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05060351 |
| 137 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03731712 |
| 138 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03615798 |
| 139 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02577909 |
| 140 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02444102 |
| 141 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02437032 |
| 142 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01211679 |
| 143 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00566447 |
| 144 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99549516 |
| 145 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99542491 |
| 146 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.99211210 |
| 147 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99056894 |
| 148 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98887066 |
| 149 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98180380 |
| 150 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97309710 |
| 151 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97045011 |
| 152 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96624950 |
| 153 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94400580 |
| 154 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94194580 |
| 155 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93820088 |
| 156 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93791858 |
| 157 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93779567 |
| 158 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93438859 |
| 159 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93405258 |
| 160 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93173615 |
| 161 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91882954 |
| 162 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90147247 |
| 163 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89797373 |
| 164 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.89748165 |
| 165 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89624732 |
| 166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88982794 |
| 167 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.88919162 |
| 168 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88497421 |
| 169 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88200840 |
| 170 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86917168 |
| 171 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86859474 |
| 172 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86508755 |
| 173 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.86391454 |
| 174 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.85460168 |
| 175 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84964065 |
| 176 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.84728597 |
| 177 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.84493436 |
| 178 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83584666 |
| 179 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.83544054 |
| 180 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83475133 |
| 181 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82744905 |
| 182 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.81984327 |
| 183 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81859055 |
| 184 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.79962767 |
| 185 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.79956640 |
| 186 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.78438908 |
| 187 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77122129 |
| 188 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.76954158 |
| 189 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.76748097 |
| 190 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.76304364 |
| 191 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75049261 |
| 192 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75044734 |
| 193 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75044734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 5.10041338 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.92898032 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.04845930 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.81996141 |
| 5 | MP0003646_muscle_fatigue | 3.79795114 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.61086958 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.45973754 |
| 8 | MP0000566_synostosis | 3.31129345 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.28542506 |
| 10 | MP0010094_abnormal_chromosome_stability | 3.18446159 |
| 11 | MP0003077_abnormal_cell_cycle | 3.03978244 |
| 12 | MP0009840_abnormal_foam_cell | 2.91045442 |
| 13 | MP0005360_urolithiasis | 2.84521421 |
| 14 | MP0008057_abnormal_DNA_replication | 2.80228072 |
| 15 | MP0004130_abnormal_muscle_cell | 2.76187453 |
| 16 | MP0005365_abnormal_bile_salt | 2.57301472 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.51678351 |
| 18 | MP0000383_abnormal_hair_follicle | 2.46914611 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.38146781 |
| 20 | MP0008058_abnormal_DNA_repair | 2.27718090 |
| 21 | MP0004134_abnormal_chest_morphology | 2.19493047 |
| 22 | MP0001730_embryonic_growth_arrest | 2.06987128 |
| 23 | MP0008007_abnormal_cellular_replicative | 2.01208330 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.96058524 |
| 25 | MP0002089_abnormal_postnatal_growth/wei | 1.95787018 |
| 26 | MP0003879_abnormal_hair_cell | 1.85642815 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 1.84782773 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.82951262 |
| 29 | MP0003718_maternal_effect | 1.82701084 |
| 30 | MP0008932_abnormal_embryonic_tissue | 1.79279052 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.72034361 |
| 32 | MP0003786_premature_aging | 1.66479643 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.64208885 |
| 34 | MP0003186_abnormal_redox_activity | 1.63763005 |
| 35 | MP0003011_delayed_dark_adaptation | 1.63556397 |
| 36 | MP0000350_abnormal_cell_proliferation | 1.63067292 |
| 37 | MP0003123_paternal_imprinting | 1.57814905 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.57369322 |
| 39 | MP0003938_abnormal_ear_development | 1.56578464 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.55919806 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.54911299 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.54911299 |
| 43 | MP0001485_abnormal_pinna_reflex | 1.54011390 |
| 44 | MP0000490_abnormal_crypts_of | 1.53999016 |
| 45 | MP0009115_abnormal_fat_cell | 1.53453219 |
| 46 | MP0003315_abnormal_perineum_morphology | 1.44034293 |
| 47 | MP0001663_abnormal_digestive_system | 1.42717560 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.41889344 |
| 49 | MP0000609_abnormal_liver_physiology | 1.40184035 |
| 50 | MP0001440_abnormal_grooming_behavior | 1.38565589 |
| 51 | MP0009053_abnormal_anal_canal | 1.37165227 |
| 52 | MP0002080_prenatal_lethality | 1.36965121 |
| 53 | MP0001764_abnormal_homeostasis | 1.35600839 |
| 54 | MP0010307_abnormal_tumor_latency | 1.35001200 |
| 55 | MP0002009_preneoplasia | 1.34321737 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.33199728 |
| 57 | MP0005380_embryogenesis_phenotype | 1.32326449 |
| 58 | MP0001672_abnormal_embryogenesis/_devel | 1.32326449 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.30426914 |
| 60 | MP0005332_abnormal_amino_acid | 1.30413280 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.28532926 |
| 62 | MP0001697_abnormal_embryo_size | 1.28532412 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.27709655 |
| 64 | MP0004742_abnormal_vestibular_system | 1.27660209 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.27594363 |
| 66 | MP0005381_digestive/alimentary_phenotyp | 1.26258006 |
| 67 | MP0003136_yellow_coat_color | 1.23293037 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.22408672 |
| 69 | MP0001853_heart_inflammation | 1.21994423 |
| 70 | MP0000313_abnormal_cell_death | 1.21908206 |
| 71 | MP0003984_embryonic_growth_retardation | 1.21105760 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 1.21065386 |
| 73 | MP0000598_abnormal_liver_morphology | 1.20830574 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.19975142 |
| 75 | MP0002088_abnormal_embryonic_growth/wei | 1.18760590 |
| 76 | MP0000358_abnormal_cell_content/ | 1.18622265 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 1.18587942 |
| 78 | MP0002398_abnormal_bone_marrow | 1.18328834 |
| 79 | MP0002722_abnormal_immune_system | 1.16777210 |
| 80 | MP0005083_abnormal_biliary_tract | 1.15786096 |
| 81 | MP0000604_amyloidosis | 1.15676867 |
| 82 | MP0003828_pulmonary_edema | 1.14725761 |
| 83 | MP0000026_abnormal_inner_ear | 1.11855093 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.09962111 |
| 85 | MP0002086_abnormal_extraembryonic_tissu | 1.08664315 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 1.08055641 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 1.07310582 |
| 88 | MP0003252_abnormal_bile_duct | 1.06438467 |
| 89 | MP0006035_abnormal_mitochondrial_morpho | 1.06377757 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 1.06253943 |
| 91 | MP0002210_abnormal_sex_determination | 1.06115933 |
| 92 | MP0008877_abnormal_DNA_methylation | 1.05921415 |
| 93 | MP0004510_myositis | 1.05317804 |
| 94 | MP0008260_abnormal_autophagy | 1.04876392 |
| 95 | MP0003195_calcinosis | 1.03892035 |
| 96 | MP0002092_abnormal_eye_morphology | 1.03528432 |
| 97 | MP0003436_decreased_susceptibility_to | 1.02993541 |
| 98 | MP0000049_abnormal_middle_ear | 1.02195302 |
| 99 | MP0005174_abnormal_tail_pigmentation | 1.00314084 |
| 100 | MP0001145_abnormal_male_reproductive | 1.00307273 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00021010 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.99817828 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.99606856 |
| 104 | MP0001929_abnormal_gametogenesis | 0.99571955 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.98789481 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98045637 |
| 107 | MP0004947_skin_inflammation | 0.97824270 |
| 108 | MP0002429_abnormal_blood_cell | 0.97565696 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.97501210 |
| 110 | MP0000858_altered_metastatic_potential | 0.96237861 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.94878435 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.94245020 |
| 113 | MP0009672_abnormal_birth_weight | 0.93880609 |
| 114 | MP0003385_abnormal_body_wall | 0.93724088 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.93113693 |
| 116 | MP0005448_abnormal_energy_balance | 0.91232984 |
| 117 | MP0000427_abnormal_hair_cycle | 0.91228224 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.90301081 |
| 119 | MP0004197_abnormal_fetal_growth/weight/ | 0.90278973 |
| 120 | MP0002085_abnormal_embryonic_tissue | 0.89291522 |
| 121 | MP0000685_abnormal_immune_system | 0.87880359 |
| 122 | MP0001800_abnormal_humoral_immune | 0.87719130 |
| 123 | MP0002653_abnormal_ependyma_morphology | 0.87406035 |
| 124 | MP0002132_abnormal_respiratory_system | 0.85760153 |
| 125 | MP0000716_abnormal_immune_system | 0.85696768 |
| 126 | MP0004019_abnormal_vitamin_homeostasis | 0.85544732 |
| 127 | MP0004233_abnormal_muscle_weight | 0.85264145 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.84578293 |
| 129 | MP0008469_abnormal_protein_level | 0.84229962 |
| 130 | MP0004883_abnormal_blood_vessel | 0.84202172 |
| 131 | MP0001666_abnormal_nutrient_absorption | 0.84031327 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.83933695 |
| 133 | MP0002160_abnormal_reproductive_system | 0.83692656 |
| 134 | MP0005266_abnormal_metabolism | 0.83329506 |
| 135 | MP0000653_abnormal_sex_gland | 0.82816705 |
| 136 | MP0005023_abnormal_wound_healing | 0.82667035 |
| 137 | MP0002118_abnormal_lipid_homeostasis | 0.81454718 |
| 138 | MP0005389_reproductive_system_phenotype | 0.81121861 |
| 139 | MP0002084_abnormal_developmental_patter | 0.79526119 |
| 140 | MP0003632_abnormal_nervous_system | 0.78652836 |
| 141 | MP0000371_diluted_coat_color | 0.77230484 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.77179898 |
| 143 | MP0002998_abnormal_bone_remodeling | 0.77042061 |
| 144 | MP0003119_abnormal_digestive_system | 0.74846134 |
| 145 | MP0000647_abnormal_sebaceous_gland | 0.74680020 |
| 146 | MP0001661_extended_life_span | 0.74097010 |
| 147 | MP0005464_abnormal_platelet_physiology | 0.74012438 |
| 148 | MP0000767_abnormal_smooth_muscle | 0.73922966 |
| 149 | MP0009764_decreased_sensitivity_to | 0.73849409 |
| 150 | MP0002723_abnormal_immune_serum | 0.73720478 |
| 151 | MP0002971_abnormal_brown_adipose | 0.72948854 |
| 152 | MP0000631_abnormal_neuroendocrine_gland | 0.72699795 |
| 153 | MP0002234_abnormal_pharynx_morphology | 0.72519375 |
| 154 | MP0001346_abnormal_lacrimal_gland | 0.71874135 |
| 155 | MP0009250_abnormal_appendicular_skeleto | 0.71657692 |
| 156 | MP0009379_abnormal_foot_pigmentation | 0.71110386 |
| 157 | MP0003172_abnormal_lysosome_physiology | 0.69830346 |
| 158 | MP0000477_abnormal_intestine_morphology | 0.69642762 |
| 159 | MP0004142_abnormal_muscle_tone | 0.68561861 |
| 160 | MP0003878_abnormal_ear_physiology | 0.68482618 |
| 161 | MP0005377_hearing/vestibular/ear_phenot | 0.68482618 |
| 162 | MP0000778_abnormal_nervous_system | 0.67984719 |
| 163 | MP0002249_abnormal_larynx_morphology | 0.66525715 |
| 164 | MP0009763_increased_sensitivity_to | 0.66171391 |
| 165 | MP0003937_abnormal_limbs/digits/tail_de | 0.66082282 |
| 166 | MP0002452_abnormal_antigen_presenting | 0.65738127 |
| 167 | MP0004043_abnormal_pH_regulation | 0.65515156 |
| 168 | MP0005451_abnormal_body_composition | 0.65415381 |
| 169 | MP0001293_anophthalmia | 0.65328119 |
| 170 | MP0005384_cellular_phenotype | 0.64775726 |
| 171 | MP0002420_abnormal_adaptive_immunity | 0.64758368 |
| 172 | MP0005636_abnormal_mineral_homeostasis | 0.63781218 |
| 173 | MP0001819_abnormal_immune_cell | 0.63752456 |
| 174 | MP0003329_amyloid_beta_deposits | 0.63690019 |
| 175 | MP0008873_increased_physiological_sensi | 0.63333101 |
| 176 | MP0000534_abnormal_ureter_morphology | 0.63263584 |
| 177 | MP0000733_abnormal_muscle_development | 0.63056905 |
| 178 | MP0000013_abnormal_adipose_tissue | 0.60350926 |
| 179 | MP0003137_abnormal_impulse_conducting | 0.59735231 |
| 180 | MP0003638_abnormal_response/metabolism_ | 0.58867071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.38161282 |
| 2 | Abnormality of the axillary hair (HP:0100134) | 5.24379678 |
| 3 | Abnormality of secondary sexual hair (HP:0009888) | 5.24379678 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.38252086 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 4.33010707 |
| 6 | Abnormal number of erythroid precursors (HP:0012131) | 4.20476069 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.05896897 |
| 8 | Clumsiness (HP:0002312) | 3.84523695 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.83327920 |
| 10 | Megalencephaly (HP:0001355) | 3.80362549 |
| 11 | Hyperglycinemia (HP:0002154) | 3.78680239 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.72692335 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.69486630 |
| 14 | Reticulocytopenia (HP:0001896) | 3.65483076 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.55601448 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.55385802 |
| 17 | Oral leukoplakia (HP:0002745) | 3.53450186 |
| 18 | Nasolacrimal duct obstruction (HP:0000579) | 3.48852572 |
| 19 | Breast hypoplasia (HP:0003187) | 3.47487498 |
| 20 | Aplasia involving bones of the extremities (HP:0009825) | 3.35213710 |
| 21 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.35213710 |
| 22 | Aplasia of the phalanges of the hand (HP:0009802) | 3.35213710 |
| 23 | Abnormality of the right ventricle (HP:0001707) | 3.30745285 |
| 24 | Macrocytic anemia (HP:0001972) | 3.28429761 |
| 25 | Multiple enchondromatosis (HP:0005701) | 3.26104629 |
| 26 | Decreased circulating renin level (HP:0003351) | 3.12857660 |
| 27 | Concave nail (HP:0001598) | 3.09694332 |
| 28 | Cerebral hypomyelination (HP:0006808) | 3.08851481 |
| 29 | Progressive muscle weakness (HP:0003323) | 3.06770938 |
| 30 | Periauricular skin pits (HP:0100277) | 3.04426063 |
| 31 | Preauricular pit (HP:0004467) | 3.04426063 |
| 32 | Oligodontia (HP:0000677) | 2.99762682 |
| 33 | Carpal bone hypoplasia (HP:0001498) | 2.92944624 |
| 34 | Hyperglycinuria (HP:0003108) | 2.89018170 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.88079344 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 2.87429602 |
| 37 | Intrahepatic cholestasis (HP:0001406) | 2.85646934 |
| 38 | Rough bone trabeculation (HP:0100670) | 2.82242120 |
| 39 | Abnormality of the renal collecting system (HP:0004742) | 2.81729596 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.81583152 |
| 41 | Pallor (HP:0000980) | 2.79274066 |
| 42 | Alopecia of scalp (HP:0002293) | 2.77150682 |
| 43 | Impulsivity (HP:0100710) | 2.69598213 |
| 44 | Abnormality of the nasal septum (HP:0000419) | 2.69218640 |
| 45 | Vaginal fistula (HP:0004320) | 2.69018903 |
| 46 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.67221339 |
| 47 | Short 4th metacarpal (HP:0010044) | 2.67221339 |
| 48 | Abnormality of the lacrimal duct (HP:0011481) | 2.66026500 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.65177013 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65177013 |
| 51 | Mesangial abnormality (HP:0001966) | 2.63986800 |
| 52 | Hyperammonemia (HP:0001987) | 2.62787577 |
| 53 | Deep venous thrombosis (HP:0002625) | 2.62635262 |
| 54 | Osteomalacia (HP:0002749) | 2.61736349 |
| 55 | Microretrognathia (HP:0000308) | 2.61183474 |
| 56 | Late onset (HP:0003584) | 2.57432904 |
| 57 | Xanthomatosis (HP:0000991) | 2.55874295 |
| 58 | Thrombocytosis (HP:0001894) | 2.54909541 |
| 59 | Megaloblastic anemia (HP:0001889) | 2.54491910 |
| 60 | Premature ovarian failure (HP:0008209) | 2.51399884 |
| 61 | Prolonged partial thromboplastin time (HP:0003645) | 2.49482800 |
| 62 | Metabolic alkalosis (HP:0200114) | 2.48257679 |
| 63 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.45840819 |
| 64 | Colon cancer (HP:0003003) | 2.45131445 |
| 65 | Depressed nasal tip (HP:0000437) | 2.45045608 |
| 66 | Abnormality of the nasolacrimal system (HP:0000614) | 2.44704777 |
| 67 | Entropion (HP:0000621) | 2.44491748 |
| 68 | Abnormality of the anterior horn cell (HP:0006802) | 2.42305653 |
| 69 | Degeneration of anterior horn cells (HP:0002398) | 2.42305653 |
| 70 | Selective tooth agenesis (HP:0001592) | 2.42210564 |
| 71 | Abnormality of reticulocytes (HP:0004312) | 2.42171080 |
| 72 | Cheilitis (HP:0100825) | 2.41895224 |
| 73 | Maternal diabetes (HP:0009800) | 2.41659314 |
| 74 | Short femoral neck (HP:0100864) | 2.40104279 |
| 75 | Secondary amenorrhea (HP:0000869) | 2.39142161 |
| 76 | Aplastic anemia (HP:0001915) | 2.38462991 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.34998912 |
| 78 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34350681 |
| 79 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34350681 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.32882890 |
| 81 | Recurrent abscess formation (HP:0002722) | 2.29555851 |
| 82 | Spastic diplegia (HP:0001264) | 2.28719343 |
| 83 | Hypoplasia of the ulna (HP:0003022) | 2.28714966 |
| 84 | Conical tooth (HP:0000698) | 2.27644918 |
| 85 | Hypolipoproteinemia (HP:0010981) | 2.27241139 |
| 86 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.22810240 |
| 87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.22432999 |
| 88 | Abnormality of permanent molar morphology (HP:0011071) | 2.21104966 |
| 89 | Abnormality of the dental root (HP:0006486) | 2.21104966 |
| 90 | Taurodontia (HP:0000679) | 2.21104966 |
| 91 | Long nose (HP:0003189) | 2.20958086 |
| 92 | Trismus (HP:0000211) | 2.20145720 |
| 93 | Hyperlipoproteinemia (HP:0010980) | 2.19164944 |
| 94 | Hypoplasia of dental enamel (HP:0006297) | 2.18691864 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.17576790 |
| 96 | Hypoplastic labia majora (HP:0000059) | 2.16498705 |
| 97 | Patellar aplasia (HP:0006443) | 2.15023466 |
| 98 | Skin pits (HP:0100276) | 2.13070842 |
| 99 | Intestinal fistula (HP:0100819) | 2.12879022 |
| 100 | Ependymoma (HP:0002888) | 2.12113063 |
| 101 | Abnormal spermatogenesis (HP:0008669) | 2.11835796 |
| 102 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.11706652 |
| 103 | CNS hypomyelination (HP:0003429) | 2.09332246 |
| 104 | Flat occiput (HP:0005469) | 2.08776846 |
| 105 | Lethargy (HP:0001254) | 2.08699202 |
| 106 | Gout (HP:0001997) | 2.08148390 |
| 107 | Neurofibrillary tangles (HP:0002185) | 2.06258092 |
| 108 | Lip pit (HP:0100267) | 2.05847103 |
| 109 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.05708208 |
| 110 | Rectal fistula (HP:0100590) | 2.04723125 |
| 111 | Rectovaginal fistula (HP:0000143) | 2.04723125 |
| 112 | IgM deficiency (HP:0002850) | 2.04537368 |
| 113 | Abnormality of the dental pulp (HP:0006479) | 2.03772404 |
| 114 | Abnormal number of incisors (HP:0011064) | 2.03658210 |
| 115 | Neoplasm of the pancreas (HP:0002894) | 2.02234000 |
| 116 | Partial duplication of thumb phalanx (HP:0009944) | 2.02167933 |
| 117 | Basal cell carcinoma (HP:0002671) | 2.01817234 |
| 118 | Abnormality of the fibula (HP:0002991) | 2.01672849 |
| 119 | Absent thumb (HP:0009777) | 2.00154193 |
| 120 | Increased serum ferritin (HP:0003281) | 2.00078377 |
| 121 | Supernumerary ribs (HP:0005815) | 2.00028654 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 2.00024218 |
| 123 | Partial duplication of the phalanx of hand (HP:0009999) | 1.99227979 |
| 124 | Increased serum lactate (HP:0002151) | 1.98385191 |
| 125 | Duplicated collecting system (HP:0000081) | 1.98235489 |
| 126 | Death in infancy (HP:0001522) | 1.98134610 |
| 127 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98130491 |
| 128 | Hypoplasia of the uterus (HP:0000013) | 1.98070265 |
| 129 | Anal stenosis (HP:0002025) | 1.97293874 |
| 130 | Personality changes (HP:0000751) | 1.96930741 |
| 131 | Abnormality of the 4th metacarpal (HP:0010012) | 1.96900670 |
| 132 | Recurrent fungal infections (HP:0002841) | 1.96543141 |
| 133 | Bilateral microphthalmos (HP:0007633) | 1.96486873 |
| 134 | Bulbous nose (HP:0000414) | 1.95284711 |
| 135 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.94639505 |
| 136 | 2-3 toe syndactyly (HP:0004691) | 1.93646152 |
| 137 | Recurrent skin infections (HP:0001581) | 1.93489793 |
| 138 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93311823 |
| 139 | Abnormality of the labia majora (HP:0012881) | 1.92866486 |
| 140 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.92488374 |
| 141 | Abnormality of molar morphology (HP:0011070) | 1.91848431 |
| 142 | Abnormality of molar (HP:0011077) | 1.91848431 |
| 143 | Petechiae (HP:0000967) | 1.91387831 |
| 144 | Pancytopenia (HP:0001876) | 1.91241529 |
| 145 | Cellular immunodeficiency (HP:0005374) | 1.91107419 |
| 146 | Hypotrichosis (HP:0001006) | 1.90945381 |
| 147 | Persistence of primary teeth (HP:0006335) | 1.90764809 |
| 148 | Labial hypoplasia (HP:0000066) | 1.89428136 |
| 149 | Abnormal trabecular bone morphology (HP:0100671) | 1.89255743 |
| 150 | Bronchomalacia (HP:0002780) | 1.86419164 |
| 151 | CNS demyelination (HP:0007305) | 1.85417394 |
| 152 | Fair hair (HP:0002286) | 1.85167377 |
| 153 | Hypercholesterolemia (HP:0003124) | 1.85060924 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.84885268 |
| 155 | Rhabdomyosarcoma (HP:0002859) | 1.84200750 |
| 156 | Mixed hearing impairment (HP:0000410) | 1.83745791 |
| 157 | Cortical visual impairment (HP:0100704) | 1.83398684 |
| 158 | Abnormality of lateral ventricle (HP:0030047) | 1.82911286 |
| 159 | Vascular calcification (HP:0004934) | 1.82847599 |
| 160 | Hyperbilirubinemia (HP:0002904) | 1.82286708 |
| 161 | Squamous cell carcinoma (HP:0002860) | 1.81411239 |
| 162 | Sparse eyelashes (HP:0000653) | 1.80629401 |
| 163 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80332792 |
| 164 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80332792 |
| 165 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.79724252 |
| 166 | Prominent nose (HP:0000448) | 1.79058926 |
| 167 | Poikiloderma (HP:0001029) | 1.78448188 |
| 168 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.77259939 |
| 169 | Absent/shortened dynein arms (HP:0200106) | 1.77259939 |
| 170 | Myocardial infarction (HP:0001658) | 1.76439310 |
| 171 | Abnormality of the intrinsic pathway (HP:0010989) | 1.76069192 |
| 172 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.75675463 |
| 173 | Anophthalmia (HP:0000528) | 1.75232462 |
| 174 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74992878 |
| 175 | Abnormality of the motor neurons (HP:0002450) | 1.74865411 |
| 176 | Abnormal neuron morphology (HP:0012757) | 1.74865411 |
| 177 | Abnormality of the 2nd finger (HP:0004100) | 1.73931394 |
| 178 | Abnormality of the frontal sinuses (HP:0002687) | 1.72982484 |
| 179 | Reticulocytosis (HP:0001923) | 1.72808082 |
| 180 | Abnormality of macrophages (HP:0004311) | 1.72612835 |
| 181 | Microvesicular hepatic steatosis (HP:0001414) | 1.72448642 |
| 182 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.72317582 |
| 183 | Delayed CNS myelination (HP:0002188) | 1.71503274 |
| 184 | Corneal erosion (HP:0200020) | 1.70975468 |
| 185 | Premature graying of hair (HP:0002216) | 1.70817012 |
| 186 | Agnosia (HP:0010524) | 1.70287161 |
| 187 | Horseshoe kidney (HP:0000085) | 1.70073382 |
| 188 | Abnormality of the common coagulation pathway (HP:0010990) | 1.70054194 |
| 189 | Paralysis (HP:0003470) | 1.69676773 |
| 190 | Muscle fiber inclusion bodies (HP:0100299) | 1.69473060 |
| 191 | Pustule (HP:0200039) | 1.69190584 |
| 192 | Proximal tubulopathy (HP:0000114) | 1.68462326 |
| 193 | Impaired platelet aggregation (HP:0003540) | 1.68051443 |
| 194 | Abnormal platelet function (HP:0011869) | 1.68051443 |
| 195 | Myelodysplasia (HP:0002863) | 1.67127332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.63218739 |
| 2 | WEE1 | 3.82057470 |
| 3 | NME2 | 3.63332585 |
| 4 | EIF2AK1 | 3.45085851 |
| 5 | STK24 | 2.91630308 |
| 6 | NEK2 | 2.77021146 |
| 7 | CAMK1D | 2.64827247 |
| 8 | TESK2 | 2.46514738 |
| 9 | CDC7 | 2.43100160 |
| 10 | CDK12 | 2.41780009 |
| 11 | BCKDK | 2.38100922 |
| 12 | STK16 | 2.38099683 |
| 13 | PNCK | 2.33402171 |
| 14 | ACVR1B | 2.33179271 |
| 15 | INSRR | 2.28056512 |
| 16 | CAMKK2 | 2.20438626 |
| 17 | TLK1 | 2.08303335 |
| 18 | TSSK6 | 2.01589189 |
| 19 | EIF2AK3 | 2.01392862 |
| 20 | CAMK1G | 1.99577230 |
| 21 | DYRK3 | 1.93629259 |
| 22 | EPHB2 | 1.87407466 |
| 23 | MAP4K1 | 1.84601881 |
| 24 | BRSK2 | 1.82273212 |
| 25 | RPS6KA4 | 1.81229192 |
| 26 | KDR | 1.75936193 |
| 27 | IRAK3 | 1.72746368 |
| 28 | MAPK15 | 1.69560741 |
| 29 | PIM2 | 1.66511418 |
| 30 | FLT3 | 1.62924867 |
| 31 | SRPK1 | 1.62853687 |
| 32 | ICK | 1.59083433 |
| 33 | NEK1 | 1.55907059 |
| 34 | SCYL2 | 1.54852783 |
| 35 | RPS6KA6 | 1.52507363 |
| 36 | PKN2 | 1.51747579 |
| 37 | SGK2 | 1.49944561 |
| 38 | RPS6KA2 | 1.48029418 |
| 39 | TAF1 | 1.46715727 |
| 40 | FGFR3 | 1.46396832 |
| 41 | PTK6 | 1.45729006 |
| 42 | RPS6KB2 | 1.42709425 |
| 43 | CDK7 | 1.41850681 |
| 44 | PLK1 | 1.41809623 |
| 45 | PHKG1 | 1.40921122 |
| 46 | PHKG2 | 1.40921122 |
| 47 | EEF2K | 1.40278222 |
| 48 | PLK4 | 1.38247534 |
| 49 | TTK | 1.38042326 |
| 50 | CHUK | 1.35343554 |
| 51 | RPS6KC1 | 1.32942183 |
| 52 | RPS6KL1 | 1.32942183 |
| 53 | MAP2K3 | 1.30763897 |
| 54 | MAP3K11 | 1.29978318 |
| 55 | EPHA2 | 1.28789933 |
| 56 | ZAP70 | 1.27543177 |
| 57 | CDK4 | 1.25924456 |
| 58 | TAOK3 | 1.25848628 |
| 59 | AURKB | 1.25609530 |
| 60 | MAP3K8 | 1.22087168 |
| 61 | CAMK4 | 1.21045751 |
| 62 | TRIB3 | 1.20942604 |
| 63 | TYRO3 | 1.20532582 |
| 64 | PRKAA2 | 1.20126915 |
| 65 | VRK1 | 1.18544918 |
| 66 | DMPK | 1.18008335 |
| 67 | TRPM7 | 1.17955051 |
| 68 | WNK1 | 1.15403256 |
| 69 | MAPK12 | 1.13669484 |
| 70 | MAP3K14 | 1.12854478 |
| 71 | AURKA | 1.10961464 |
| 72 | ERBB2 | 1.10297561 |
| 73 | STK10 | 1.10092279 |
| 74 | PASK | 1.09977422 |
| 75 | SGK494 | 1.08735360 |
| 76 | SGK223 | 1.08735360 |
| 77 | ATR | 1.08626332 |
| 78 | MAP3K2 | 1.07893187 |
| 79 | BRSK1 | 1.05370630 |
| 80 | TGFBR1 | 1.03471269 |
| 81 | BLK | 1.01821746 |
| 82 | PIM1 | 1.01310071 |
| 83 | IRAK2 | 1.00891475 |
| 84 | CAMKK1 | 0.99088245 |
| 85 | ERN1 | 0.98308999 |
| 86 | SGK3 | 0.97971628 |
| 87 | MAPKAPK3 | 0.97436085 |
| 88 | DYRK1B | 0.96385284 |
| 89 | IRAK4 | 0.93696705 |
| 90 | AKT3 | 0.90515445 |
| 91 | SIK1 | 0.89956090 |
| 92 | WNK4 | 0.87678266 |
| 93 | BRD4 | 0.87530613 |
| 94 | MAP3K10 | 0.86934946 |
| 95 | CHEK2 | 0.85666444 |
| 96 | MKNK1 | 0.84808582 |
| 97 | GRK6 | 0.83109244 |
| 98 | MAP2K4 | 0.81324390 |
| 99 | STK11 | 0.80042822 |
| 100 | MKNK2 | 0.79961483 |
| 101 | TESK1 | 0.79882502 |
| 102 | TYK2 | 0.78910304 |
| 103 | CHEK1 | 0.78723452 |
| 104 | LRRK2 | 0.78665967 |
| 105 | RPS6KA1 | 0.78103056 |
| 106 | PDK3 | 0.75504056 |
| 107 | PDK4 | 0.75504056 |
| 108 | PAK4 | 0.75363916 |
| 109 | SIK2 | 0.75360387 |
| 110 | FGFR4 | 0.75099403 |
| 111 | PAK1 | 0.72601362 |
| 112 | ADRBK2 | 0.70705137 |
| 113 | FGFR2 | 0.69924956 |
| 114 | FRK | 0.67969500 |
| 115 | CSNK2A2 | 0.67751324 |
| 116 | MAP2K2 | 0.67011492 |
| 117 | OBSCN | 0.66588139 |
| 118 | TBK1 | 0.65753315 |
| 119 | MAPK7 | 0.64546904 |
| 120 | ITK | 0.63862551 |
| 121 | ABL2 | 0.61603131 |
| 122 | SGK1 | 0.60953863 |
| 123 | HIPK2 | 0.60072921 |
| 124 | TAOK2 | 0.59929230 |
| 125 | TAOK1 | 0.59286175 |
| 126 | TTN | 0.59135573 |
| 127 | PRKCG | 0.59095002 |
| 128 | MAP3K3 | 0.58442131 |
| 129 | RAF1 | 0.58353648 |
| 130 | PLK3 | 0.58249768 |
| 131 | BRAF | 0.57559059 |
| 132 | MAPK11 | 0.56217329 |
| 133 | CDK2 | 0.55758071 |
| 134 | CSNK2A1 | 0.52878183 |
| 135 | IRAK1 | 0.52600867 |
| 136 | MAP3K5 | 0.52379317 |
| 137 | PRKCZ | 0.52137339 |
| 138 | RPS6KB1 | 0.50802165 |
| 139 | IKBKE | 0.50620743 |
| 140 | BTK | 0.48790478 |
| 141 | JAK3 | 0.47844950 |
| 142 | NEK9 | 0.46793839 |
| 143 | ALK | 0.46310872 |
| 144 | CCNB1 | 0.45396516 |
| 145 | JAK2 | 0.43527136 |
| 146 | CDK6 | 0.43065332 |
| 147 | KIT | 0.42786377 |
| 148 | STK4 | 0.42670391 |
| 149 | NLK | 0.42573471 |
| 150 | MATK | 0.42323620 |
| 151 | PAK2 | 0.42040722 |
| 152 | PRKACG | 0.41508930 |
| 153 | ATM | 0.40754971 |
| 154 | TEC | 0.39650944 |
| 155 | SYK | 0.39622050 |
| 156 | PDGFRB | 0.39224826 |
| 157 | PRKCI | 0.39163303 |
| 158 | FGFR1 | 0.39103563 |
| 159 | RPS6KA5 | 0.38644896 |
| 160 | IKBKB | 0.37290008 |
| 161 | MARK3 | 0.36927281 |
| 162 | PDPK1 | 0.36750161 |
| 163 | PKN1 | 0.36327550 |
| 164 | SMG1 | 0.36321639 |
| 165 | PRKACA | 0.34943738 |
| 166 | LATS2 | 0.34660555 |
| 167 | CSF1R | 0.34282845 |
| 168 | MTOR | 0.33134131 |
| 169 | NME1 | 0.32636980 |
| 170 | AKT2 | 0.31804082 |
| 171 | MAP2K6 | 0.30680917 |
| 172 | STK3 | 0.30577447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.58853801 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.38759716 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.33624463 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.27722117 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.00468323 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.97098650 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.70313783 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.50886324 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.48711867 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.48181236 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.46203365 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.42959404 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.38199647 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.31802961 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.22020849 |
| 16 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.21862510 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 2.09660787 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 2.06064703 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.00248394 |
| 20 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.97452231 |
| 21 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.97141902 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.96831079 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.96710901 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86896324 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.85082309 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.84441980 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77370436 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70327418 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.64308248 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62687361 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.59351100 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.57483837 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.53150614 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.52538935 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46630724 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.43396297 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.39800794 |
| 38 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.34358825 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33493919 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32375117 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.31584118 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28140609 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25769464 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23670908 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19327046 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17543598 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16775991 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16472994 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15800615 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15114432 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 1.15070572 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15000719 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13226362 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12190932 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.10827999 |
| 56 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.10780162 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 1.10713237 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 1.09203077 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08418511 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08103225 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05891281 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 1.05325653 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04923746 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04389566 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.02204071 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01149308 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00075551 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99927550 |
| 69 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.97999691 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97588015 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97333485 |
| 72 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.92286465 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91317306 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90302239 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88975407 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87392872 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85730265 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85596120 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84785410 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.84595017 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83965220 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81601124 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79794790 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79692682 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.78030189 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77915846 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.77444896 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76061993 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75233793 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.74521182 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74500615 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73592813 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72689202 |
| 94 | Axon guidance_Homo sapiens_hsa04360 | 0.72313628 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72017789 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71142185 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70973526 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70562877 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69974333 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69659177 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68189111 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68106752 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67845602 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67045590 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66299056 |
| 106 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66233904 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65970924 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65881512 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65610935 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65377847 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65236742 |
| 112 | Peroxisome_Homo sapiens_hsa04146 | 0.65033177 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64770935 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64016195 |
| 115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62337721 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61936388 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60719015 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.59238327 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58638885 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58133163 |
| 121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57964470 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.57340073 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57077375 |
| 124 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56678519 |
| 125 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54152652 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54006673 |
| 127 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53807414 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53337313 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52408180 |
| 130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52182508 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52042368 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52004455 |
| 133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51759162 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51265328 |
| 135 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50701392 |
| 136 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50643359 |
| 137 | Morphine addiction_Homo sapiens_hsa05032 | 0.50589351 |
| 138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50480546 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49491906 |
| 140 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49413909 |
| 141 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49370229 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49350511 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48714901 |
| 144 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47983444 |
| 145 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47969643 |
| 146 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46949632 |
| 147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46478493 |
| 148 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46196178 |
| 149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45903166 |
| 150 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45407057 |
| 151 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44671435 |
| 152 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44374854 |
| 153 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44359493 |
| 154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44189297 |
| 155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44018496 |
| 156 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42566794 |
| 157 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41566080 |
| 158 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40421162 |
| 159 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39392457 |
| 160 | Prostate cancer_Homo sapiens_hsa05215 | 0.39142863 |
| 161 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39126801 |
| 162 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38694577 |
| 163 | Lysosome_Homo sapiens_hsa04142 | 0.38421947 |
| 164 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37249447 |
| 165 | Legionellosis_Homo sapiens_hsa05134 | 0.37080117 |
| 166 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36140988 |
| 167 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36094808 |
| 168 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35451666 |
| 169 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35319955 |
| 170 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34798073 |
| 171 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34226279 |
| 172 | Protein export_Homo sapiens_hsa03060 | 0.31720109 |
| 173 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30031834 |
| 174 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.28066401 |
| 175 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26656852 |
| 176 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26380649 |
| 177 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24264615 |
| 178 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23788537 |
| 179 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23391069 |
| 180 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22212791 |
| 181 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22140448 |
| 182 | Apoptosis_Homo sapiens_hsa04210 | 0.21513259 |
| 183 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18843266 |
| 184 | Shigellosis_Homo sapiens_hsa05131 | 0.18389957 |

